Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clazosentan thorough QT crossover study in healthy volunteers
NL-OMON46268Phase 1Active, not recruiting
- Sponsor
- Idorsia
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of clazosentan in cerebral vasospasm (3 arms), sponsored by Idorsia. Primary endpoint: Cardiodynamic variables. Started Sep 2018; status: active, not recruiting.
02
Drugs
clazosentan
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NL-OMON46268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46268.